SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

AstraZeneca Pharma India informs about resignation of senior management personnels

12 Jun 2026 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), AstraZeneca Pharma India has informed that Aditi Mehta, Business Unit Director - Oncology Business Unit, of the Company has decided to pursue a career outside the organization. Mehta will complete her handover period and be relieved from duties by the close of business hours on June 12, 2026. The Company is in the process of looking for a suitable replacement for this position; Srikanth B.S., Site Lead, India Operations has decided to pursue a career outside the organization. Srikanth will complete his handover period and be relieved from duties by the close of business hours on June 15, 2026. These being Senior Management Personnel position in terms of the SEBI Listing Regulations, the company has enclosed details as required under the SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, attached as Annexure- A, alongwith their respective copies of the resignation letters enclosed.

The above information is a part of company’s filings submitted to BSE. 

Astrazeneca Pharma I Share Price

8243.90 -4.90 (-0.06%)
12-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.25
Dr. Reddys Lab 1273.90
Cipla 1388.80
Zydus Lifesciences 1104.35
Lupin 2292.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: